Back to search results

CTNow: Education Program for Rural Cancer Patients

This study, called CTNow, is testing a program designed to help rural cancer patients and their doctors learn more about cancer clinical trials. The program involves multimedia educational videos for patients and workshops via Zoom for healthcare providers. The goal is to see if these educational tools can increase patients' understanding and knowledge of clinical trials over 18 months. You may be able to join if you are 18 or older, have been diagnosed with any cancer, and can read, write, and speak English. You can be currently receiving treatment, have received treatment, or be starting treatment within 90 days. The study plans to enroll 50 participants, but its current recruitment status is unclear.

Study design
This is an interventional study that plans to enroll 50 participants. It is testing an educational program for both patients and providers.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will measure changes in patient awareness and knowledge of clinical trials at 18 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06237816

CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers

Recruiting
NAAges 18+InterventionalHealth services
University of Hawaii
~50 participants
Updated 2026-04-03 on ClinicalTrials.gov
What's tested:Patient Education InterventionProvider Education Intervention

At a glance

Recruiting sites
3 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in patients' awareness and knowledge of clinical trials
Measured over 18 months

Conditions

Cancer
Oncology

Explore related trials

Malignant Neoplasm

Where it's being run

3 sites across 1 states
Hawaii3

Study leadership

  • Izumi Okado, PhD · PRINCIPAL_INVESTIGATOR · University of Hawaii Cancer Research Center

Who to contact

Izumi Okado, PhD
[email protected]
(808) 564-5978
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients must have been diagnosed with any cancer.
Patients who have received treatment, are receiving cancer treatment at the time of enrollment, or estimated to start treatment within 90 days.
Patients must be ≥ 18 years of age. Patients must be able to read, write, and speak English. Study materials and telephone calls are only available in English.

Exclusion

Patients must not have previously participated in a cancer clinical trial. Those who have participated in a cancer clinical trial are not eligible for the study.

What this trial measures

  • Change in patients' awareness and knowledge of clinical trials18 months

    Participants will complete a 12-item awareness and knowledge of clinical trials questionnaire at baseline and post-intervention. Items are reported on a Likert-type scale , with higher scores indicating greater knowledge. A paired t-test will be used to evaluate whether there is a statistically significant difference in pre- and post-intervention scores on patients' knowledge of clinical trials.